Optimization of a new artemisinin-based combination therapy of artesunate-piperaquine fixed-dose combination tablet with enhanced in vivo antimalarial effects

Van Han Nguyen Trong Bien Tran Ngoc Bao Tran Viet Hoang Nguyen Quang Anh Luong Thi Tien Nong   

Open Access   

Published:  Dec 26, 2022

DOI: 10.7324/JAPS.2023.120449

This work aimed to develop a new fixed-dose combination tablet (FDCT) containing artesunate (ART) 50 mg and piperaquine 320 mg for enhanced malaria parasites treatment. Firstly, the physico-chemical properties of ART were improved effectively by forming solid dispersions (SDs) with β-cyclodextrin. Secondly, the FDCT was prepared by direct compression method using ART SDs and piperaquine phosphate (PQP). The formulation was experimented with full factorial design and optimized by Modde 5.0 software. FDCT were assessed for physical properties, drug content assay, dissolution, stability, acute toxicity, and in vivo antimalarial efficacy. ART and PQP assays were performed by using the validated high-performance liquid chromatography and UV spectrophotometry methods. Dissolution tests were conducted as per US Pharmacopoeia version 43 (USP43). The in vivo antimalarial activity of ART-PQP FDCT was assessed on mice infected with chloroquine-resistant Plasmodium berghei. The obtained FDCT met all desirable physical properties with an average weight of 670 mg, weight variation range of 690.5–702.9 mg per tablet, hardness range of 64-68N, friability of 0.5%–0.6%, and disintegration of 7–8 minutes. The contents of ART and PQP per tablet were 51.3–52.6 mg and 322.1–330.8 mg, respectively. The dissolution of ART and PQP within 30 minutes were more than 90% and 80%, respectively. Acute toxicity was identified with LD50 value in mice of 1,550.5 mg/kg. The cure rate of FDCT on mice of 93.3% was distinctly higher than that of single ART or PQP. The new ART-PQP FDCT showed enhanced antimalaria activity over monotherapies against chloroquine-resistant Plasmodium berghei.

Keyword:     Fixed-dose combination antimalaria artesunate piperaquine solid dispersion


Nguyen VH, Tran TB, Tran NB, Nguyen VH, Luong QA, Nong TT. Optimization of a new artemisinin-based combination therapy of artesunate-piperaquine fixed-dose combination tablet with enhanced in vivo antimalarial effects. J Appl Pharm Sci, 2022. https://doi.org/10.7324/JAPS.2023.120449

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Ashok CI, Yogesh AS, Bonnie AA, Mitchell AA, Christy MW. Interaction of Artemisinin and Its Related Compounds with Hydroxypropyl-b-cyclodextrin in Solution State: Experimental and Molecular-Modeling Studies. J Pharm Sci, 2003; 92(3):649-55. https://doi.org/10.1002/jps.10319

Baird JK. Effectiveness of Antimalarial Drugs. N Engl J Med, 2005; 352:1565-77. https://doi.org/10.1056/NEJMra043207

Barradell LB, Fitton A. Artesunate: A Review of its Pharmacology and Therapeutic Efficacy in the Treatment of Malaria. Drugs, 1995; 50(4):714-41. https://doi.org/10.2165/00003495-199550040-00009

Bashira A, Hamidb SA, Badawic A, Geneidib AS. Enhancing dissolution of artesunate from immediate release tablets using a green granulation technique. Arch Pharm Sci ASU, 2019; 3(1):55-77. https://doi.org/10.21608/aps.2019.20230

Davis TME, Hung TY, Sim IK, Karunajeewa HA, Ilett KF. Piperaquine: A Resurgent Antimalarial Drug. Drugs, 2005a; 65(1):75-87. https://doi.org/10.2165/00003495-200565010-00004

Davis TME, Karunajeewa HA, Ilett KF. Artemisinin?based combination therapies for uncomplicated malaria. Med J Aust, 2005b; 182(4):181-5. https://doi.org/10.5694/j.1326-5377.2005.tb06650.x

Drug Bank: Amodiaquine. Available at: http://www.drugbank.ca/drugs/DB00613 [Accessed 6 October 2021].

Drug Bank: Mefloquine. Available at: http://www.drugbank.ca/drugs/DB00358 [Accessed 6 October 2021].

Hartell MG, Hicks R, Bhattacharjee AK, Koser BW, Carvalho K, Hamont JEV. Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with β-cyclodextrin. J Pharm Sci, 2004; 93(8):2076-89. https://doi.org/10.1002/jps.20106

Ho HN, Tran TH, Tran TB, Chul SY, Nguyen NC. Optimization and Characterization of Artesunate-Loaded Chitosan-Decorated Poly(D,L-lactide-co-glycolide) Acid Nanoparticles. J Nanomater, 2015; Article ID 674175. https://doi.org/10.1155/2015/674175

ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1). 1994.

Kim DW, Weon KY. Pharmaceutical application and development of fixed-dose combination: dosage form review. J Pharm Investig, 2021; 51:555-70 https://doi.org/10.1007/s40005-021-00543-x

Lee HY, Lee YJ. A Data Analysis Tool for Drug Stability with R. Available at: http://pkpd.kmu.edu.tw/stability/ [Accessed 6 October 2021].

Li G, Li Y, Li Z, Zeng M. Dihydroartemisinin and Artemisinin in Combination With Piperaquine (Artekin, Artequick); Primaquine and Malaria Transmission; and Malaria Elimination. In: Xiuping Z, Zhixiang Z, Guoqiao L. Artemisinin-Based and Other Antimalarials, Academic Press. 2018; 609-70. https://doi.org/10.1016/B978-0-12-813133-6.00010-X

Lyu HN, Ma N, Meng Y, Zhang X, Wong YK, Xu C, Liao F, Jiang T, Tu Y, Wang J. Study towards improving artemisinin-based combination therapies. Nat Prod Rep, 2021; 38(7):1243-50. https://doi.org/10.1039/D0NP00079E

Martins AC, Paoliello MMB, Docea AO, Santamaria A, Tinkov AA, Skalny AV, Aschner M. Review of the mechanism underlying mefloquine-induced neurotoxicity. Crit Rev Toxicol, 2021; 51(3):209-16. https://doi.org/10.1080/10408444.2021.1901258

Myint HY, Ashley EA, Day NP, Nosten F, White NJ. Efficacy and safety of dihydroartemisinin-piperaquine. Trans R Soc Trop Med Hyg, 2007; 101(9):858-66. https://doi.org/10.1016/j.trstmh.2007.05.018

Newton P, Suputtamongkol Y, TI Paktiya, Pukrittayakamee S, Navaratnam V, Bates I, White N. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Am Soc Microbiol, 2000; 44(4):972-7. https://doi.org/10.1128/AAC.44.4.972-977.2000

Nguyen NC, Tran NB, Do TT, Nguyen TH, Nguyen TN. D-Optimal Optimization and Data-Analysis Comparison Between a DoE Software and Artificial Neural Networks of a Chitosan Coating Process onto PLGA Nanoparticles for Lung and Cervical Cancer Treatment. J Pharm Innov, 2018; 14(3):206-20. https://doi.org/10.1007/s12247-018-9345-x

Ogbonn JDN, Attama AA, Ofokansi KC, Patil SB, Basarkar GD. Optimization of formulation processes using Design Expert® Software for preparation of polymeric blends-artesunate-amodiaquine HCl microparticles. J Drug Deliv Sci Technol, 2017; 39:36-49. https://doi.org/10.1016/j.jddst.2017.02.011

Osmo R , Reija D, Rauno VA. Blood Parasites and Male Fitness in the Pied Flycatcher. Oecologia, 1993; 96(3):410-4. https://doi.org/10.1007/BF00317512

Peters W, Portus JH, Robinson BL. The chemotherapy of rodent malaria. XXII. The value of drug-resistant strains of P. berghei in screening for blood schizonticidal activity. Ann Trop Med Parasitol, 1975; 69:155-71. https://doi.org/10.1080/00034983.1975.11686997

Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. China: ‎People's Medical Publishing House, 2015.

Shapiro TA, Goldberg DA. Analgesic-antipyretic and antiinflammatory agents; pharmacotherapy of gout. In: Goodman and Gilman's the pharmacological basis of therapeutics, 11th Edition. USA: McGraw-Hill Medical Publishing Division. 2006; 1021-7.

Shaundarya K, Dinesh C, Rakesh S, Vijay KS, Usha R, Vaibhav PS. Bioavailbility enhancement of artesunate using solid dispersion techniques. World J Pharm Pharm Sci, 2014; 3(2):1578-95.

Tran TH, Christiane D, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong THA, Tran TT, Kasia S, Nicholas JW, Jeremy F. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet, 2004; 363:18-22. https://doi.org/10.1016/S0140-6736(03)15163-X

Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov, 2007; 12(23-24):1068-75. https://doi.org/10.1016/j.drudis.2007.09.005

WHO Prequalification Team. Artemisinin Derivatives: Summary of Nonclinical Safety Data, Introductory Remarks. 2016; 1-57.

World Health Organisation. Guidelines for the Treatment of Malaria, WHO Press, Geneva. 2006.

World Health Organization. World malaria report 2020: 20 years of global progress and challenges. 2020.

Article Metrics

0 Absract views 3 PDF Downloads 3 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required